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Abstract
Concise and general strategies for radical-based dimerization of cyclotryptamine and
cyclotryptophan derivatives in addition to radical-based oxidation of structurally complex
diketopiperazines are discussed. The impact of these radical-based chemistries on the rapid
generation of molecular complexity is highlighted using representative examples from recent
complex homodimeric alkaloid total syntheses. Additionally, a new and general strategy for
radical-based directed heterodimerization of cyclotryptamine substructures via solvent-caged
unsymmetrical diazene fragmentation is discussed.
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Radical chemistry has long been recognized as an important tool for the rapid generation of
molecular complexity. Radical intermediates have proven their utility in numerous
cyclization cascades,[1] formation of challenging sterically congested bonds,[2] and as key
intermediates en route to the functionalization of often-inert chemical motifs.[3] Through our
studies in the area of cyclotryptamine and cyclotryptophan-derived natural products, we
have not only harnessed the power of radical chemistry to access natural products in a
concise manner, but we have also highlighted how the orthogonal reactivity profile of
radical intermediates can be used to efficiently elaborate intricate substructures that are
highly sensitive to polar transformations.[4] As seen in the following examples, radical
chemistry is an invaluable tool in the chemist’s quest to navigate the ever-increasing
complexities as they seek to expand the frontiers of total synthesis.
Consistent with the hypotheses set forth in the 1950s by Woodward and Robinson,[5] the
biogenesis of the dimeric cyclotryptamines and the more complex dimeric
epidithiodiketopiperazines is believed to arise from the oxidative radical dimerization of
tryptamine and tryptophan-derived monomeric subunits. This dimerization mode effectively
establishes the vicinal quaternary carbon centers in a highly convergent manner. While the
viability of an oxidative dimerization route had previously been demonstrated for the
syntheses of carbon–carbon linked dimeric alkaloids such as (+)-chimonanthine (3, Scheme
1), each of these methods produced a mixture of C(2)-symmetric and meso C(3)–C(3’)
dimeric cores.[6] In contrast, we sought a practical strategy to address the issue of both
relative and absolute stereochemical control in the synthesis of such a prevalent core
structure.[7] Seeking to exploit the convergent nature and efficiency of a radical-radical
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recombination event, we opted to access the radical species through a stepwise 2e− oxidation
followed by 1e− reduction. Our first application of this approach is highlighted in our
enantioselective synthesis of (+)-chimonanthine (3, Scheme 1).[8] Encouraged by seminal
reports by Crich and Danishefsky[9] on the utility of C(3)-functional cyclotryptamine
derivatives,[10] we envisioned the tricyclic benzylic bromide (+)-1 and related derivatives[11]
to serve as versatile precursors to the desired radical intermediates en route to homodimeric
complex alkaloids. The cis-fused 5,5-bicyclic ring system preserves the stereochemistry at
the tertiary benzylic stereocenters even despite reduction of the benzylic halide to a
stereochemically labile radical species.
After significant experimentation, we recognized that the desired single electron reduction
of the tertiary benzylic bromide (+)-1 could be most practically accomplished using
tris(triphenylphosphine) cobalt(I) chloride.[8] The rapidity of this reduction generates a large
concentration of radicals, which undergo radical recombination and afford the desired
dimeric advanced intermediates of interest. Treating intermediate (+)-1 with this cobalt
complex yielded dimer (+)-2 in 60% isolated yield on multi-gram scale, affording a concise
synthetic solution to (+)-chimonanthine (3) and other related calycanthaceous alkaloids.[8]
Notably, our Co(I)-promoted radical dimerization of cyclotryptamine derivatives has been
successfully applied to the synthesis of a number of other alkaloids.[4,11,12] In particular, this
chemistry enabled the first total synthesis of (+)-11,11’-dideoxyverticillin A (9, Scheme 2)
which embodied the intricate and fascinating molecular architecture of dimeric
epidithiodiketopiperazine alkaloids.[4] Treatment of tetracyclic bromide (+)-4 with this
cobalt complex afforded the dimer (+)-5 in 46% yield en route to (+)-9 (Scheme 2). With
rapid access to the dimeric molecular framework in only six steps from commercially
available material, we sought the development of a general strategy to access the more
highly functionalized epidithiodiketopiperazine natural products. We had postulated
early[13] in our retrobiosynthetic analysis[14] that the existing carbon–sulfur bonds in the
natural product may arise from the incorporation of a nucleophilic sulfur source via
intermediacy of an N-acyliminium ion.[15] We envisioned access to such a reactive
intermediate by ionization of a hemiaminal that in turn could be prepared by hydroxylation
of the Cα centers of the diketopiperazine.[16]
Our initial attempts to oxidize this amino acid residue via enolate chemistry were fraught
with complications arising from the formation of complex diastereomeric mixtures, partial
hydroxylation, as well as decomposition products. We quickly discovered that the
hemiaminal substructure found in the desired product (+)-6 was extremely labile to both
acidic and basic conditions, rendering such conditions incompatible with the desired
transformation. We thus turned our attention to methods based on radical chemistry. We
expected the Cα–H bond of the amino acid residues to be particularly labile toward radical
abstraction owing to the captodative stabilization afforded by the adjacent carbonyl and
amide functional groups.[4] While we found that Cα–H abstraction was unfeasible using
carbon- or oxygen-based radical sources, with the former resulting in no reaction and the
latter resulting in substrate decomposition, after significant experimentation, we discovered
that bromine radical sources were able to oxidize the Cα-centers of simple monomeric
substrates efficiently. We reported that the use of N-bromosuccinimide and AIBN as an
initiator in refluxing carbon tetrachloride afforded us the oxidized product (Scheme 3).[4]
The Cα-Br bond, however, was extremely labile in the absence of proximal inductively
withdrawing substituents, resulting in rapid ionization and elimination to the enamide
substructure, which subsequently underwent further bromination to a tetrabrominated
intermediate 11.[17] Reduction of this compound with sodium iodide then afforded a
bis(α,β-unsaturated) diketopiperazine 12 with the desired oxidation state. Notably, under
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acidic conditions, diene 12 was a competent precursor to the N-acyliminium ions required
for the anticipated nucleophilic thiolation.[4]
We were, however, unable to translate this oxidation-thiolation approach to the more
complex dimer owing to the additional sensitivity of the C(3)–C(3’) bond toward
fragmentation during formation of an analogous tetraene intermediate. Careful analysis of
the bond dissociation energies (BDE) involved in our earlier bromine-mediated radical
abstraction combined with the realization that the average BDE of a formyl C–H bond was
approximately that of an H–Br bond led us to explore the use of permanganate-based
reagents to effect the desired tetrahydroxylation reaction. In organic solvents, several studies
have demonstrated that aldehydes are oxidized by permanganate reagents to their
corresponding carboxylic acids via a radical mechanism.[18] Indeed, the use of
tetrabutylammonium permanganate in pyridine, conditions originally developed for
aldehyde oxidation,[19] on our dimeric substrate (+)-5 afforded the first samples of the
desired tetrahydroxylated intermediate (+)-6 in 9% yield. The yield was improved to 40%
upon refinement of our isolation techniques for this highly polar and sensitive
tetrahydroxylated compound. Ultimately, optimizing around solvent and counterion led us to
employ Py2AgMnO4 in dichloromethane, which afforded the desired product in 63% yield
(Scheme 2). Importantly, the tetrahydroxylated product was obtained as a single
diastereomer. It was revealed through X-ray diffraction analysis that all four hydroxylations
had occurred with retention of stereochemistry, consistent with a rapid abstraction-rebound
mechanism.[20] A compilation of our studies employing a variety of conditions, including
the successful application of tetrabutylammonium permanganate as described above,
indicate that this is a permanganate-mediated rather than a silver-mediated transformation.
The oxidation of a cyclopropyl hydantoin radical probe 13 (Scheme 4) indicated that the
rebound carbon–oxygen bond formation occurs on a faster time-scale than the ring opening
of the expected cyclopropyl methyl radical intermediate.[4] With gram-scale access to our
key tetraol intermediate, we were able to evaluate a variety of sulfidation methods, the most
successful of which involved the acid-mediated ionization of the hemiaminals and trapping
with a trithiocarbonate. Rapid unraveling of the bis(dithiepanethione) using ethanolamine in
acetone followed by an oxidative workup resulted in the first total synthesis of a dimeric
epidithiodiketopiperazine, namely the natural alkaloid (+)-11,11’-dideoxyverticillin A (9,
Scheme 2).
Having secured a general method for the synthesis of the core molecular framework of the
homodimeric cyclotryptamine and epidithiodiketopiperazine based alkaloids, we sought a
general method for the synthesis of the corresponding heterodimeric molecular foundation.
Such heterodimeric structures are found in a variety of natural products such as meso-
chimonanthine[21] and (+)-leptosin K.[22]
Although the previously described cobalt-mediated radical homodimerization of
cyclotryptamine derived subunits has proven successful for the synthesis of a number of
natural products, the application of this chemistry to the synthesis of heterodimeric
substructures proved challenging. For example, treatment of a racemic mixture of tricyclic
bromide (±)-15 with tris(triphenylphosphine)cobalt(I) chloride resulted in the formation of
the desired meso-16 in only 16% yield along with (±)-17 (16% yield) (Scheme 5).[23] The
unselective nature of this dimerization reaction in addition to the presence of undesired
disproportionation products, and the complications in product isolation from such a complex
mixture, restricts the use of this chemistry for advanced stage heterodimer formation. In
order to circumvent these challenges, we recently developed a general strategy for the
directed synthesis of heterodimeric cyclotryptamines.[23] This process is based on the
photolytic fragmentation of dialkyl diazenes to form localized radicals whose recombination
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within a solvent-cage resulted in the selective formation of the desired heterodimeric
products.
Our synthetic strategy centered on the expulsion of dinitrogen from an unsymmetrical
diazene 18 to form a pair of carbon-centered radicals whose recombination would result in
the formation of the desired heterodimer 19 (Scheme 6). Despite the rich history of dialkyl
diazenes in the field of physical organic chemistry,[24] their utilization in complex molecule
synthesis has been examined sparingly. Although ring contraction via the use of cyclic
diazenes has precedence in complex molecule synthesis,[25] the corresponding acyclic
diazene derivatives have received far less attention possibly due to the additional challenge
of intermolecular recombination of the resulting radical pair upon extrusion of
dinitrogen.[26] Indeed, disproportionation and crossover products are often observed as
major byproducts in the context of acyclic dialkyl diazene fragmentation.
We first examined the practicality of our diazene based fragment assembly in the context of
the homodimerization of complex cyclotryptophan derivatives (Scheme 7). The symmetrical
diazene (+)-21 was prepared via oxidation of the corresponding sulfamide (+)-20 in the
presence of N-chlorosuccinimide and 2-tert-butylimino-2-diethylamino-1,3-
dimethylperhydro-1,3,2-diazaphosphorine (BEMP). We found that irradiation of (+)-21 led
to expulsion of dinitrogen and formation of the desired dimeric hexacycle (+)-17 in 60%
yield. The overall efficiency of the process was improved when the freshly prepared crude
diazene was used without chromatographic purification. A representative synthesis of a
mixed sulfamide is illustrated in Scheme 8. The sulfamoyl chloride 22, accessed from the
corresponding amine (+)-19 (Scheme 7), was treated with amine 23 (Scheme 8) to afford the
desired mixed sulfamide (+)-24 in 86% yield. Oxidation of the sulfamide as described above
provided the desired diazene 25 which upon irradiation in tert-butanol afforded the desired
heterodimer (+)-26 in 68% yield from (+)-24. Notably, neither of the two possible
homodimeric products was observed by HPLC analysis of the crude product mixture.
Further insight into the critical directed fragment assembly step in a solvent-cage was
gleaned from exposure of an equal mixture of symmetrical sulfamides 20 and 27 (Scheme 9)
to the two-step oxidation and photolysis resulting in the exclusive formation of the
homodimeric products 17 and 28 (55% and 51% yield, respectively). HPLC analysis of the
crude reaction mixture did not reveal any of the heterodimeric product 29, highlighting the
superb level of control in this guided fragment union via solvent-caged radical
recombination.[23] Further investigation into the solvent-cage effects revealed high
selectivity for recombination versus disproportionation. Oxidation and subsequent
photolysis of sulfamide (+)-20 (Scheme 10) in the presence of excess 1,4-cyclohexadiene (5
equiv), a H-atom donor, resulted in an almost equal mixture of the dimeric product (+)-17
(45% yield) and the corresponding C(3a)-H reduction product (+)-30 (22% yield, ~1:1 molar
ratio). Increasing the amount of 1,4-cyclohexadiene (20 equiv) afforded a similar result.[23]
Comparatively, treatment of tricyclic bromide (+)-15 (Scheme 11) with
tris(triphenylphosphine) cobalt(I) chloride in the presence of 1,4-cyclohexadiene (5 or 20
equiv) afforded exclusively the reduction product (+)-30 in 54% and 82% yields,
respectively. These results are consistent with a solvent-cage-directed radical-pair
combination in our diazene-based directed fragment assembly.
This newly developed directed fragment assembly holds great potential for application in
complex settings as illustrated by successful preparation of heterodimeric products
illustrated in Fig. 1.[23] Notably, heterodimer (+)-31 resulting from the coupling of a
tetracyclic diketopiperazine with a cyclotryptamine derivative represents a directed and
exclusive heterodimeric union of dissimilar subunits. Furthermore, selective synthesis of
meso-16, a structural core found in many cyclotryptamine natural products, can be directly
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compared to our exploratory and unguided synthesis utilizing our cobalt promoted
cyclotryptamine dimerization (Scheme 5). Additionally, aryl-alkyl diazenes were also found
to undergo fragmentation and coupling to afford C(3a)-arylated products (+)-32 and (+)-33,
exhibiting a Csp3–Csp2 linkage found in a variety of natural alkaloids, with similar efficiency
to the corresponding alkylalkyl diazenes.[23] Overall the application of diazenes as traceless
linkers and radical precursors allows for the generation of localized radicals whose union
within the solvent-cage provides an exciting general strategy for directed heterodimeric
assembly.
In conclusion, the synthesis of a variety of dimeric alkaloids has been realized with the aid
of selective radical coupling and oxidation reactions. Furthermore heterodimeric molecular
substructures have been accessed via diazene fragmentation followed by solvent-caged
radical recombination. These newly developed general strategies allow for the selective
synthesis of a variety of cyclotryptamine and cyclotryptophan-based natural products.
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